Kelly A. Carrigan, Ph.D. - Publications

University of North Carolina, Chapel Hill, Chapel Hill, NC 

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2008 Saurer TB, Ijames SG, Carrigan KA, Lysle DT. Neuroimmune mechanisms of opioid-mediated conditioned immunomodulation. Brain, Behavior, and Immunity. 22: 89-97. PMID 17689049 DOI: 10.1016/J.Bbi.2007.06.009  0.774
2007 Carrigan KA, Dykstra LA. Behavioral effects of morphine and cocaine in M1 muscarinic acetylcholine receptor-deficient mice. Psychopharmacology. 191: 985-93. PMID 17211651 DOI: 10.1007/S00213-006-0671-1  0.499
2006 Saurer TB, Carrigan KA, Ijames SG, Lysle DT. Suppression of natural killer cell activity by morphine is mediated by the nucleus accumbens shell. Journal of Neuroimmunology. 173: 3-11. PMID 16364456 DOI: 10.1016/J.Jneuroim.2005.11.009  0.795
2005 Fischer BD, Carrigan KA, Dykstra LA. Effects of N-methyl-D-aspartate receptor antagonists on acute morphine-induced and l-methadone-induced antinociception in mice. The Journal of Pain : Official Journal of the American Pain Society. 6: 425-33. PMID 15993820 DOI: 10.1016/J.Jpain.2005.02.003  0.558
2005 Saurer TB, Carrigan KA, Ijames SG, Lysle DT. #121 A role for neuropeptide Y in the suppression of natural killer cell activity by morphine Brain, Behavior, and Immunity. 19: e63. DOI: 10.1016/J.Bbi.2005.10.128  0.76
2004 Carrigan KA, Saurer TB, Ijames SG, Lysle DT. Buprenorphine produces naltrexone reversible alterations of immune status. International Immunopharmacology. 4: 419-28. PMID 15037219 DOI: 10.1016/J.Intimp.2004.01.011  0.789
2004 Saurer TB, Carrigan KA, Ijames SG, Lysle DT. Morphine-induced alterations of immune status are blocked by the dopamine D2-like receptor agonist 7-OH-DPAT. Journal of Neuroimmunology. 148: 54-62. PMID 14975586 DOI: 10.1016/J.Jneuroim.2003.11.006  0.79
2003 Elliott JC, Picker MJ, Nelson CJ, Carrigan KA, Lysle DT. Sex differences in opioid-induced enhancement of contact hypersensitivity. The Journal of Investigative Dermatology. 121: 1053-9. PMID 14708606 DOI: 10.1046/J.1523-1747.2003.12569.X  0.777
2002 Lanier RK, Ijames SG, Carrigan KA, Carelli RM, Lysle DT. Self-administration of heroin produces alterations in the expression of inducible nitric oxide synthase. Drug and Alcohol Dependence. 66: 225-33. PMID 12062457 DOI: 10.1016/S0376-8716(01)00203-4  0.72
2001 Lysle DT, Carrigan KA. Morphine-6beta-glucuronide modulates the expression of inducible nitric oxide synthase. Inflammation. 25: 267-75. PMID 11580103 DOI: 10.1023/A:1010924320902  0.738
2001 Carrigan KA, Lysle DT. Morphine-6 beta-glucuronide induces potent immunomodulation. International Immunopharmacology. 1: 821-31. PMID 11379038 DOI: 10.1016/S1567-5769(01)00020-0  0.728
2000 Nelson CJ, Carrigan KA, Lysle DT. Naltrexone administration attenuates surgery-induced immune alterations in rats. The Journal of Surgical Research. 94: 172-7. PMID 11104658 DOI: 10.1006/Jsre.2000.6003  0.756
2000 Carrigan KA, Nelson CJ, Lysle DT. Endomorphin-1 induces antinociception without immunomodulatory effects in the rat. Psychopharmacology. 151: 299-305. PMID 11026735 DOI: 10.1007/S002130000487  0.81
Show low-probability matches.